A16Z Capital Management, L.L.C. Portfolio Stock Holdings
A16Z Capital Management, L.L.C. disclosed 16 stock positions valued at approximately $1.3 billion in its latest SEC 13F filing. The largest holdings include META PLATFORMS INC, REVOLUTION MEDICINES INC, and NAUTILUS BIOTECHNOLOGY INC. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 16
- Portfolio Value
- $1.3B
Holdings by Sector
A16Z Capital Management, L.L.C. Portfolio Holdings in Q1 2026
6 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| META PLATFORMS INC | META | Communication Services | 9.42% | 212,531 | - | - | $121,595,361 |
| REVOLUTION MEDICINES INC | RVMD | Healthcare | 6.94% | 921,099 | - | - | $89,576,878 |
| NAUTILUS BIOTECHNOLOGY INC | NAUT | Healthcare | 5.31% | 17,653,917 | - | - | $68,497,198 |
| BLOCK INC | SQ | Technology | 4.74% | 1,016,697 | - | - | $61,184,825 |
| ERASCA INC | ERAS | Healthcare | 3.59% | 2,862,500 | - | - | $46,315,250 |
| GINKGO BIOWORKS HOLDINGS INC | DNA | Other | 0.05% | 108,568 | - | - | $665,522 |